Skip to main content

Table 6 Comparison of the efficacy in different treatment duration

From: Efficacy and safety of caspofungin for patients with hepatic insufficiency

Group

Complete response

Partial response

Stable response

Progression of disease

Death

Efficient (%)

1 week

2 weeks

3 weeks

X2

P

4

5

1

1.269

0.652

46

40

30

6.998

0.030

12

10

5

1.985

0.369

9

8

6

0.700

0.715

8

9

8

0.690

0.711

63.3

62.5

63.3

1.416

0.084

Total

10

116

27

22

25

63.0